OA, K., MJ, S., HE, B., KR, B., & R, R. (2017). An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer. Oncotarget, 8(3), 4484. https://doi.org/10.18632/oncotarget.13152
Chicago Style (17th ed.) CitationOA, Kent, Sandí MJ, Burston HE, Brown KR, and Rottapel R. "An Oncogenic KRAS Transcription Program Activates the RHOGEF ARHGEF2 to Mediate Transformed Phenotypes in Pancreatic Cancer." Oncotarget 8, no. 3 (2017): 4484. https://doi.org/10.18632/oncotarget.13152.
MLA (9th ed.) CitationOA, Kent, et al. "An Oncogenic KRAS Transcription Program Activates the RHOGEF ARHGEF2 to Mediate Transformed Phenotypes in Pancreatic Cancer." Oncotarget, vol. 8, no. 3, 2017, p. 4484, https://doi.org/10.18632/oncotarget.13152.